Andre Sisdeli is currently the Head of Market Access at Merck Group, where they lead efforts to optimize reimbursement and funding for innovative therapies across public and private markets. Previously, they served as a Senior Manager of Strategic Accounts and Institutional Sales at Merck Brasil, overseeing a strategic portfolio valued at R$250 million. Andre's extensive background in oncology includes roles at Roche, where they managed teams and developed market strategies for oncology products. They are pursuing a Master of Science in Health Care Economics and Management at the Universidade de São Paulo, building on prior degrees including an MBA from Fundação Getulio Vargas.
This person is not in any teams
This person is not in any offices